The limited number of therapeutic options for several oncological and hematological diseases and recent advances in antibody engineering and conjugation technologies have made antibody-drug conjugates (ADCs) an emerging option for cancer treatment. ADCs have a complex structure comprised of a...
The Clinical and Translational Toxicology Specialty Section (CTTSS), founded in 2011, is one of the newer SOT Specialty Sections. A focus of the CTTSS is improving the management of human poisoning by using a translational approach that links molecular mechanisms to rational therapy. The ...
The Society of Toxicology (SOT) Component Groups (Regional Chapters, Special Interest Groups, and Specialty Sections) and other Committee groups host many webinars throughout the year. Webinars are an effective distance-learning method intended to impart scientific knowledge to members of their...
Research Beyond Basic Science: Pursuing Topics in Clinical and Translational Toxicology 2:30 PM EST, Wednesday, February 14 Panelists: Sarah Campion, Jaime Mirowsky, and Nisha Sipes This webinar will explore the transition of both trainee scientists and established investigators from...
Putting Lessons Learned from SOT Scientific Sessions into Practice Before I proceed with my report on the 2017 Workshop Session "Safety or Prediction? What is the Future of Regulatory Toxicity Testing," it would be appropriate to state my Conflict of Interest (COI) and bias, which is a...
Toxicologists, other scientists, and clinicians generally agree that dietary supplements are safe for consumption when used appropriately. However, all recognize that there is a paucity of toxicity information available on them, as most human toxicity data must come from post-market analysis and...
11190 Sunrise Valley Dr., Suite 300,Reston, VA 20191 703.438.3115 sothq@toxicology.org
Join SOTJoin a Component GroupManage Your ProfileVolunteer
Privacy PolicyCode of ConductCode of Ethics